Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 100 movers: AstraZeneca rallies; Severn Trent in the red
(Sharecast News) - London's FTSE 100 was down 0.2% at 8,411.78 in afternoon trade on Tuesday. AstraZeneca rallied as it laid out plans to hit $80bn in revenue by 2030.
Russ Mould, investment director at AJ Bell, said: "Having stepped up to the plate and delivered on its $45 billion revenue goal set a decade earlier, AstraZeneca is now reaching for the stars with a new target to hit $80 billion revenue by 2030. The market liked the bold ambition, sending the shares to the upper part of the FTSE 100 leader board.
"An easy way for AstraZeneca to achieve such a goal would be to go on a spending spree and buy up rival companies. However, AstraZeneca implies it will hit the goal through organic means which would be all the more impressive.
"Chief executive Pascal Soriot is no stranger to controversy over the scale of his pay packet so perhaps he is trying to justify the large renumeration with the new growth plan. Achieving the goal would imply significant value generation for shareholders and no doubt himself given that part of his bonus scheme will be based on company performance.
"Developing new medicines is not an easy task as the success rate is unpredictable. Even when something is approved for commercial sale, there is always the risk of copycat products once patents expire. AstraZeneca needs to spin multiple plates at the same time as it cannot go 'all in' on one area, in case of failure or setback."
Severn Trent was under the cosh after South West Water owner Pennon slashed its dividend by £2.4m following a record fine for illegally dumping sewage into rivers and the sea.
FTSE 100 - Risers
Schroders (SDR) 377.00p 1.78% Flutter Entertainment (DI) (FLTR) 16,525.00p 1.32% AstraZeneca (AZN) 12,188.00p 0.76% Tesco (TSCO) 312.70p 0.74% Reckitt Benckiser Group (RKT) 4,568.00p 0.71% Antofagasta (ANTO) 2,406.00p 0.54% Next (NXT) 9,410.00p 0.45% Imperial Brands (IMB) 1,945.50p 0.31% London Stock Exchange Group (LSEG) 9,356.00p 0.30% Centrica (CNA) 146.60p 0.27%
FTSE 100 - Fallers
easyJet (EZJ) 459.90p -3.16% Smith (DS) (SMDS) 367.00p -2.39% BT Group (BT.A) 129.25p -2.27% RS Group (RS1) 810.50p -2.23% Scottish Mortgage Inv Trust (SMT) 870.00p -2.16% Hikma Pharmaceuticals (HIK) 1,932.00p -2.08% Vodafone Group (VOD) 75.78p -1.79% Prudential (PRU) 790.80p -1.79% Melrose Industries (MRO) 608.00p -1.78% Severn Trent (SVT) 2,588.00p -1.71%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
